CA2111672A1 - Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis - Google Patents

Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis

Info

Publication number
CA2111672A1
CA2111672A1 CA002111672A CA2111672A CA2111672A1 CA 2111672 A1 CA2111672 A1 CA 2111672A1 CA 002111672 A CA002111672 A CA 002111672A CA 2111672 A CA2111672 A CA 2111672A CA 2111672 A1 CA2111672 A1 CA 2111672A1
Authority
CA
Canada
Prior art keywords
iid6
peptide
amino acids
cytochrome
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002111672A
Other languages
English (en)
French (fr)
Inventor
Fernando Alvarez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2111672A1 publication Critical patent/CA2111672A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002111672A 1991-06-17 1992-06-16 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis Abandoned CA2111672A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9107363A FR2677653A1 (fr) 1991-06-17 1991-06-17 Fragments peptidiques issus du cytochrome humain p450 iid6, anticorps anti-fragments peptidiques et leurs applications dans le diagnostic de l'hepatite auto-immune.
FR91/07363 1991-06-17

Publications (1)

Publication Number Publication Date
CA2111672A1 true CA2111672A1 (en) 1992-12-23

Family

ID=9413909

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002111672A Abandoned CA2111672A1 (en) 1991-06-17 1992-06-16 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis

Country Status (9)

Country Link
US (1) US5830667A (enExample)
EP (1) EP0589993B1 (enExample)
JP (1) JP3284240B2 (enExample)
AT (1) ATE180512T1 (enExample)
CA (1) CA2111672A1 (enExample)
DE (1) DE69229269T2 (enExample)
ES (1) ES2133320T3 (enExample)
FR (1) FR2677653A1 (enExample)
WO (1) WO1992022656A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985542A (en) * 1996-05-20 1999-11-16 Sumitomo Chemical Company, Limited Diagnostic kit
DE19805815C1 (de) * 1998-02-13 1999-11-11 Ansgar W Lohse Diagnostikum zum Erkennen der autoimmunen Hepatitis
DE19930933B4 (de) * 1998-07-10 2005-05-25 Imtec Immundiagnostika Gmbh Verfahren zur Bestimmung von anti-LKM 1-Antikörpern
US6787303B1 (en) 1999-04-01 2004-09-07 Alton Ochsner Medical Foundation Identification of a novel retrovirus associated with primary sclerosing cholangitis and autoimmune hepatitis
CA2421680A1 (en) * 2000-09-29 2002-04-04 Merck & Co., Inc. Antibodies for human cytochrome p450 2d6
US20040096874A1 (en) * 2002-04-11 2004-05-20 Third Wave Technologies, Inc. Characterization of CYP 2D6 genotypes
EP2454276A4 (en) * 2008-07-17 2013-07-10 Inter K Pty Ltd THERAPEUTIC AGENTS
CN102955030A (zh) * 2012-06-11 2013-03-06 郑州安图绿科生物工程有限公司 检测自身免疫性肝病相关抗体ana的试剂盒及其检测方法
CN102707055A (zh) * 2012-06-11 2012-10-03 郑州安图绿科生物工程有限公司 一种联合或单独检测自身免疫性肝病相关抗体的试剂盒及其检测方法
CN102955027A (zh) * 2012-06-11 2013-03-06 郑州安图绿科生物工程有限公司 检测自身免疫性肝病相关抗体抗lc-1抗体的试剂盒及其检测方法
CN102955026A (zh) * 2012-06-11 2013-03-06 郑州安图绿科生物工程有限公司 检测自身免疫性肝病相关抗体asma的试剂盒及其检测方法
CR20230131A (es) 2015-05-06 2023-06-23 Immatics Biotechnologies Gmbh NUEVOS PÉPTIDOS Y NUEVAS COMBINACIONES DE PÉPTIDOS Y DE SOPORTES PARA LA INMUNOTERAPIA CONTRA EL CARCINOMA COLORRECTAL Y OTROS TIPOS DE CÁNCER (Divisional Exp. 2017-0497)
GB201507719D0 (en) 2015-05-06 2015-06-17 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
EP3477303A1 (en) 2017-10-27 2019-05-01 Medizinische Hochschule Hannover Method and means for diagnosing autoimmune hepatitis using autoantibody markers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV

Also Published As

Publication number Publication date
JP3284240B2 (ja) 2002-05-20
EP0589993A1 (fr) 1994-04-06
JPH06510663A (ja) 1994-12-01
US5830667A (en) 1998-11-03
ATE180512T1 (de) 1999-06-15
ES2133320T3 (es) 1999-09-16
DE69229269T2 (de) 1999-11-11
FR2677653A1 (fr) 1992-12-18
FR2677653B1 (enExample) 1995-04-14
EP0589993B1 (fr) 1999-05-26
WO1992022656A1 (fr) 1992-12-23
DE69229269D1 (de) 1999-07-01

Similar Documents

Publication Publication Date Title
Lenzi et al. Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection.
Richardson et al. Procyclin: an unusual immunodominant glycoprotein surface antigen from the procyclic stage of African trypanosomes
US5348876A (en) IgG3 antibodies with shortened hinge region and a complement activation test
US5166050A (en) Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
CA2305192C (en) Method for assaying hepatitis c virus
KR920008744B1 (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
CA2111672A1 (en) Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis
US6040137A (en) Antigen/antibody specification exchanger
Budkowska et al. Hepatitis B virus (HBV) binding factor in human serum: candidate for a soluble form of hepatocyte HBV receptor
US5869232A (en) Antigen/antibody specificity exchanger
JPS61501912A (ja) 合成ポリペプチドにより誘発されたヒトインタ−ロイキン−２に対する抗体
JPS62500027A (ja) エプスタイン、バールウィルス核抗原と免疫反応する抗体を産生する化学的に合成されたポリペプチド
US5871904A (en) Immunassay of non-A, non-B hepatitis virus-related antigens, monoclonal antibodies for use therein, and hybridomas producing the antibodies
DK175332B1 (da) Apo Al polypeptid, monoklonalt antistof, diagnostisk system og fremgangsmåde til mængdebestemmelse af Apo Al samt hybridom
Richardson et al. Targeted antipeptide antibodies to cytochrome P450 2C18 based on epitope mapping of an inhibitory monoclonal antibody to P450 2C51
Edwards et al. Antibodies to a synthetic peptide that react specifically with a common surface region on two hydrocarbon-inducible isoenzymes of cytochrome P-450 in the rat
Davis et al. Characterization of HDJ-2, a human 40 kD heat shock protein
Mo et al. The C-terminal segment of the cysteine-rich interdomain of Plasmodium falciparum erythrocyte membrane protein 1 determines CD36 binding and elicits antibodies that inhibit adhesion of parasite-infected erythrocytes
JP4166940B2 (ja) Ｈｉｖウイルスに対して免疫反応性である抗体の検出用の合成抗原
CA1341391C (en) Protective peptides derived from human immunodeficiency virus-1 gp160
JP3978226B2 (ja) アルコール中毒患者を同定しアルコール消費を監視するためのイムノアッセイ
Chiang et al. Immunochemical studies of the purified human platelet receptor for the alpha 1 (I)-chain of chick skin collagen.
KR0127148B1 (ko) 발현 마커(marker)로서 HBxAg를 함유하는 SV40발현 벡터
AU774887B2 (en) Antigenic epitopes and mosaic polypeptides of hepatitis C virus proteins
Marchalonis et al. The immunoglobulin-like T cell receptor—IV: Quantitative cellular assay and partial characterization of a heavy chain cross-reactive with the Fd fragment of serum μ chain

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued